C83.63 Undifferentiated (diffuse) non-Hodgkin's lymphoma, intra-abdominal lymph nodes

Name of the Condition

• Undifferentiated (diffuse) non-Hodgkin's lymphoma, intra-abdominal lymph nodes
• Also known as ICD-10 code C83.63

Summary

Undifferentiated (diffuse) non-Hodgkin's lymphoma is a subtype of non-Hodgkin lymphoma characterized by the malignant proliferation of lymphoid cells that lack distinct differentiation or follicular structure. It typically involves abnormal growth of B-cells or T-cells in lymph nodes or other lymphoid tissues, with a diffuse pattern of spread. This condition specifically affects the intra-abdominal lymph nodes and is part of the broader category of non-follicular lymphomas.

Causes

The exact cause of undifferentiated (diffuse) non-Hodgkin's lymphoma remains unknown. It is thought to involve genetic mutations or abnormalities in lymphoid cell development, though specific triggers are not well-defined. Research suggests potential links to immune system dysregulation or prior infections, but no definitive etiology has been established.

Risk Factors

• Age: More common in older adults.
• Family history of lymphoma.
• Prior exposure to radiation or certain chemicals.
• Chronic infections, such as hepatitis C or HIV.
• Immunosuppressive conditions or treatments.

Symptoms

• Swollen, painless lymph nodes in the abdominal area.
• Unexplained weight loss.
• Fever.
• Night sweats.
• Fatigue.
• Loss of appetite.
• Abdominal pain or discomfort.
• Nausea or vomiting.

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or MRI scans) to identify enlarged intra-abdominal lymph nodes, and biopsy of the affected tissue to confirm the presence of malignant lymphoid cells. Additional tests, such as blood work or bone marrow biopsy, may be performed to assess disease extent and subtype. Pathological analysis is critical to distinguish this condition from other lymphomas or malignancies.

Treatment Options

Treatment depends on the stage, subtype, and patient health but may include chemotherapy, immunotherapy, targeted therapy, or radiation therapy. In some cases, a combination of these approaches is used. Clinical trials or novel therapies may be considered for advanced or refractory cases. Treatment plans are tailored to individual patient needs and response.

Prognosis and Follow-Up

Prognosis varies based on factors like disease stage, subtype, and patient age. Regular follow-up with imaging and clinical assessments is essential to monitor for recurrence or progression. Long-term surveillance helps manage potential complications and adjust treatment as needed.

Complications

Potential complications include organ dysfunction due to lymph node compression, infection risk from immunosuppression, treatment-related side effects (e.g., cytopenias), and transformation to a more aggressive lymphoma subtype. Metastasis to other sites may also occur.

Lifestyle & Prevention

While prevention is not fully established, maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known risk factors (e.g., excessive radiation exposure) may support overall health. Early detection through prompt evaluation of symptoms is key.

When to Seek Professional Help

Seek medical attention for persistent abdominal swelling, unexplained weight loss, fever, night sweats, or fatigue. Prompt evaluation is important if symptoms worsen or new concerning signs (e.g., severe pain, jaundice) develop.

Tips for Medical Coders

Use code C83.63 for undifferentiated (diffuse) non-Hodgkin's lymphoma specifically involving intra-abdominal lymph nodes. Ensure documentation supports the anatomical site and confirms the diagnosis. Verify that the condition is not better classified under another lymphoma subtype or site-specific code.